Company Quick10K Filing
China Crawfish
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 55 $-0
10-K 2019-03-28 Annual: 2018-10-31
10-Q 2018-09-21 Quarter: 2018-07-31
10-Q 2018-06-21 Quarter: 2018-04-30
10-Q 2018-03-26 Quarter: 2018-01-31
10-K 2018-02-14 Annual: 2017-10-31
10-Q 2017-09-20 Quarter: 2017-07-31
10-Q 2017-06-16 Quarter: 2017-04-30
10-Q 2017-05-03 Quarter: 2017-01-31
10-K 2017-04-11 Annual: 2016-10-31
10-Q 2016-11-29 Quarter: 2016-07-31
10-Q 2016-06-28 Quarter: 2016-04-30
10-Q 2016-05-27 Quarter: 2016-01-31
10-K 2016-04-25 Annual: 2015-10-31
8-K 2018-02-08 Enter Agreement, Exhibits
8-K 2018-02-03 Enter Agreement, Sale of Shares

China Crawfish Financials

CACA Metrics, Comps, Filings

Annual | Quarterly

Business

We were incorporated in the State of Nevada on September 15, 2015. China Crawfish, Ltd. was previously is an import company specializing in bringing wedding and evening dresses from Asia (specifically China) to be sold online to anyone in Latin America. We have recently initiated a new business line by entry into a Share Exchange Agreement (the "Share Exchange Agreement"), dated as of February 8, 2018, by and among the Company, Qian Jiang LiRong Biotechnology, Ltd, a corporation organized under the laws of the People's Republic of China ("Qian Biotech") and the shareholders of Qian Biotech (the "Shareholders"). Pursuant to the Share Exchange Agreement, at the closing thereof (the "Closing"), the Company agreed to exchange the outstanding shares of common stock of Qian Biotech held by the Shareholders for an aggregate of 20,836,900 shares of common stock of the Company, or approximately 27.32% of the issued and outstanding share of common stock of the Company after giving effect to such issuance..

The Share Exchange Agreement contemplates that the issuance of shares of our Common Stock to holders of Qian Biotech's equity interests in connection therewith will be exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof, which exempts transactions by an issuer not involving any public offering, and Regulation D and Regulation S under that section, and that these securities, when issued, may not be offered or sold in the United States absent such registration or an applicable exemption from such registration requirements, and will be subject to further contractual restrictions on transfer as described in the Merger Agreement.

The Share Exchange Agreement and the transactions contemplated thereby have been approved by the board of directors of the Company and Qian Biotech. The share agreement has not been consummated.


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($ Annual)

Operating, Investing, Financing

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
mPhase Technologies (XDSL) 19% -0.0 -113% 10,681,966,000 10,291,858,000 10,069,612,000 1,863,098,000 -12,063,027,000 -11,928,933,000 175,679,000
Protective Life Insurance (PLICO) 0% -0.3 0% 118,726,116,000,000 107,434,197,000,000 5,753,173,000,000 0 531,796,000,000 727,294,000,000 -223,300,002,000
IMH Financial (IFCN) 0% -2.9 -11% 152,559,000,000 66,663,000,000 8,118,000,000 0 -16,675,000,000 -14,007,000,000 40,987,999,000
Northstar/RXR New York Metro Real Estate (RXR) 0% -2.1 6% 46,628,839,000 271,254,000 3,791,710,000 0 2,853,794,000 2,853,794,000 -6,134,903,000
ABV Consulting (ABVN) 0.1 -1,121% 4,348,000 299,092,000 0 0 -48,720,000 -48,720,000 -4,350,000
Northwest Pipeline (NWP) 0% 4.4 5% 2,230,691,000,000 1,079,466,000,000 334,839,000,000 0 108,583,000,000 130,405,000,000 576,806,999,000
China Crawfish (CACA) 0.1 -966% 2,499,000 0 0 0 -24,147,000 -24,147,000 -2,501,000
Twinlab Consolidated Holdings (TLCC) 16% -11.7 -26% 63,058,000,000 122,859,000,000 57,558,000,000 9,331,000,000 -16,542,000,000 -7,632,000,000 89,019,999,000
Westmoreland Resource Partners (OXF) 0% -4.4 -53% 235,297,000,000 436,663,000,000 194,887,000,000 0 -123,945,000,000 -65,022,000,000 288,286,999,000
Alpha Energy (ALPHA) -31% 0.0 -586% 42,941,000 681,696,000 3,857,000 -1,212,000 -251,744,000 -228,412,000 -5,352,000
John Deere Capital (JDCC) 0% 9.0 1% 40,089,900,000,000 35,961,500,000,000 2,890,300,000,000 0 419,500,000,000 2,267,900,000,000 20,396,099,999,000
Icagen (ICFN) 39% -3.3 -59% 12,455,702,000 35,928,023,000 10,373,966,000 4,027,049,000 -7,397,157,000 -3,655,023,000 12,100,669,000
Wound Management Technologies (WNDM) 90% 0.7 -19% 3,480,225,000 4,567,095,000 7,070,810,000 6,330,734,000 -665,021,000 -574,926,000 -419,165,000
International Leaders Capital (ILCC) 0% 0.1 -718% 210,539,000 1,014,166,000 46,884,000 0 -1,510,907,000 -1,585,159,000 -97,134,000
Baynon (BNON) 0.6 -217% 8,625,000 149,716,000 0 0 -18,728,000 -15,521,000 -8,627,000
Divall Insured Income (DIVXZ) -0.8 11% 4,181,072,000 134,859,000 0 0 449,976,000 560,347,000 -475,576,000
Baying Ecological (BYIN) 0.0 0 264,826,000 0 0 -42,269,000 -42,269,000 -2,000
Eco Tek 360 (ETEK) 0% 0.1 -205% 453,824,000 2,460,588,000 1,784,000 0 -931,925,000 -920,522,000 -50,229,000
Multi Soft II (MSOF) 15.2 -117% 32,758,000 749,671,000 0 0 -38,362,000 -2,156,000 -32,760,000
Jobbot (JBBT) 0.0 0 5,160,000 0 0 -15,426,000 -11,378,000 -2,000

Balance Sheet ($)2015-10-312016-10-312017-10-312018-10-31
Cash2,468,0007,276,0002,499,0002,499,000
Accounts Receivable
Inventory
PP&E
Assets2,468,0007,276,0002,499,0002,499,000
Accounts Payable
Long-Term Debt6,216,0006,216,000
Liabilities6,216,0006,216,00000
Stockholders' Equity-5,717,000
Income Statement ($)2015-10-312016-10-312017-10-312018-10-31
Revenue0000
Cost of Revenue
Gross Profit
R&D
SG&A00
Tax00
Net Income-7,632,000-16,061,000-6,777,000-6,777,000
Cash Flow ($)2015-10-312016-10-312017-10-312018-10-31
Cash Operating-7,632,000-16,061,000-6,777,000-6,777,000
Cash Investing00
Cash Financing-20,869,0002,000,0002,000,000